Mitotech
Engineering Software · New Mexico, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
590 Monte Alto, Santa Fe, New Mexico, 87...Phone Number
(505) 670-0232Website
www.mitotech.netRevenue
$8.2 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Mitotech
The principles have developed software systems for DNA sequencing systems, chromatography data, and mass spectral data. Mitotech is a small business located inExplore more
Popular SearchesMitotech LLCMitotechSIC Code 73,737NAICS Code 51,513Show moreMitotech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Mitotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if Mitotech had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Mitotech
Check out if Mitotech is spiking on competitors!
Mitotech, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Mitotech launches new products
Earning: See what the market has to say on Mitotech recently announced quarterly report
Funding: Get notified immidiatlly once Mitotech has new funding data
Check if Mitotech has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Mitotech
Compare insights from companies similar to Mitotech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$26.6M
201-500
Private
-
2007
AD
Aurelien DalleGlobal Support Hardlines Vice President, Customer Success
Company Profile Activity
Activity Insights
Mitotech is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Mitotech is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Mitotech.
Mitotech Tech Stack
Mitotech News & Media
Mitotech and Essex Bio-Technology announce positive results of VISTA-2...
Both VISTA-2 and VISTA-1 demonstrated significant impact of SkQ1 on clearing of Central Corneal Fluorescein Staining (CCFS) and improvement of Best Corrected Visual Acuity (BCVA) at day 28 (p<0.05... (PRWeb February 26, 2021) Read the full story at https://www.prweb.com/releases/mitotech_and_essex_bio_technology_announce_positive_results_of_vista_2_phase_3_clinical_study_in_dry_eye_disease/prweb17752486.htmMitotech and Essex Bio-Technology Complete Enrollment in VISTA-2 – a pivotal Phase 3 Clinical Study of SkQ1 for Dry Eye Disease
Mitotech and Essex Bio-Technology completed enrollment in a Phase 3 clinical study of SkQ1 ophthalmic solution in Dry Eye Disease (DED) patients. This new study is targeting confirmation of the early onset of improvements across DED signs and symptoms demonstrated in VISTA-1 study in 2019. (PRWeb August 25, 2020) Read the full story at https://www.prweb.com/releases/mitotech_and_essex_bio_technology_complete_enrollment_in_vista_2_a_pivotal_phase_3_clinical_study_of_skq1_for_dry_eye_disease/prwebMitotech and Essex Bio-Technology Announce Enrollment in VISTA-2 – a...
A Phase 3 clinical study in Dry Eye Disease patients has been initiated by Mitotech SA in the U.S. in co-development with Essex Bio-Technology targeting confirmation of the early onset of improvements... (PRWeb December 17, 2019) Read the full story at https://www.prweb.com/releases/mitotech_and_essex_bio_technology_announce_enrollment_in_vista_2_a_pivotal_phase_3_clinical_study_of_skq1_for_dry_eye_disease/prweb16785220.htmMitotech Completes First Patient Visit in VISTA-1 - Phase 3 Clinical Study of SkQ1 for Dry Eye Disease
Mitotech announces completion of the first visit of first patient in its Phase 3 clinical trial of SkQ1 molecule for Dry Eye Disease (PRWeb October 29, 2018) Read the full story at https://www.prweb.com/releases/mitotech_completes_first_patient_visit_in_vista_1_phase_3_clinical_study_of_skq1_for_dry_eye_disease/prweb15875230.htm
Read more news
Top Engineering Software Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Mitotech
Sign Up For FreeTo access detailed company insights
The principles have developed software systems for DNA sequencing systems, chromatography data, and mass spectral data. Mitotech is a small business located in... Read More
